Assessment of Problematic Use of Benzodiazepines and Z Drugs in the Elderly in France: a Public Health Issue
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Benzodiazepines and Related Drugs Users
- Sponsor
- Nantes University Hospital
- Enrollment
- 1100
- Locations
- 11
- Primary Endpoint
- Dependence according to DSM IV criteria
- Last Updated
- 12 years ago
Overview
Brief Summary
The aim of this study is to evaluate benzodiazepines and related drugs (zolpidem and zopiclone) usage in an outpatient population of chronic users over 65 years in France using a questionnaire assessing substance dependence according to DSM-IV (Diagnostic and Statistical Manual of mental disorders) international standards.
Detailed Description
1100 patients will be recruited by pharmacists. They will answer to a standardized questionnaire assessing their benzodiazepines or related drugs usage (phone contact). Pharmacists are recruited by all French Centers For Evaluation and Information on Pharmacodependence (CEIP).
Investigators
Eligibility Criteria
Inclusion Criteria
- •65 years old or more,
- •benzodiazepines or benzodiazepines related drugs treatment for at least three months,
- •written consent and without exclusion criteria.
Exclusion Criteria
- •no written consent form
- •difficulties to understand or speak french
Outcomes
Primary Outcomes
Dependence according to DSM IV criteria
Time Frame: 2 years
Secondary Outcomes
- psychiatric comorbidities(2 years)
- Dependence scores(2 years)
- withdrawal syndrome(2 years)